Although neither of them has been directly related to cancer, other members of the PAQR family of progesterone receptors are known tumor suppressors, while TDRD6 has been reported as frequently down-regulated in breast cancer, suggesting its potential use as biomarker35. Here, PGR is linked to cancer.